Package leaflet: Information for the user Oxycodone Hydrochloride Teva 5 mg Capsules, hard Oxycodone Hydrochloride Teva 10 mg Ca
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2011 to 30 April 2
![Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended‐Release Oxycodone Formulations with Abuse‐Deterrent Properties - Gudin - 2015 - Pain Medicine - Wiley Online Library Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended‐Release Oxycodone Formulations with Abuse‐Deterrent Properties - Gudin - 2015 - Pain Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c4054b03-93d1-4284-aff5-24d0d47537f5/pme12834-fig-0001-m.jpg)